\n
\r\n<\/a>\r\n<\/p>\n<\/div><\/section><\/div>
\r\n\r\n
<\/a>\r\n<\/div><\/p>\n<\/div><\/section>
\nHermes Pharma to invest \u20ac 25 million to bolster manufacturing capabilities for oral dosage forms<\/h1>E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>

\n
Hermes Pharma to invest \u20ac 25 million to bolster manufacturing capabilities for oral dosage forms<\/h1>E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\nGermany-based Hermes Pharma, a leading expert in user-friendly oral dosage forms, has announced it will invest \u20ac25 million to further bolster its manufacturing capabilities. The investment will arm the company with new equipment, increased production and storage capacity, and greater operational efficiency to meet the rapidly growing market demand for user-friendly oral dosage forms. As a result, Hermes Pharma will be able to further drive future growth, while helping new and existing customers to realise theirs.<\/h3>\n<\/p>\n
The pharmaceutical industry has long seen traditional tablets and capsules as the \u201cgold standard\u201d of oral dosage forms. However, around 50% of people struggle to take them. Consequently, demand for easy-to-swallow oral dosage forms, such as orally disintegrating granules (ODGs), chewable tablets, lozenges, instant drinks, and effervescents, is soaring, with healthcare companies seeking to add them to their portfolios.<\/p>\n<\/div><\/section>
\n
Germany-based Hermes Pharma, a leading expert in user-friendly oral dosage forms, has announced it will invest \u20ac25 million to further bolster its manufacturing capabilities. The investment will arm the company with new equipment, increased production and storage capacity, and greater operational efficiency to meet the rapidly growing market demand for user-friendly oral dosage forms. As a result, Hermes Pharma will be able to further drive future growth, while helping new and existing customers to realise theirs.<\/h3>\n<\/p>\n
The pharmaceutical industry has long seen traditional tablets and capsules as the \u201cgold standard\u201d of oral dosage forms. However, around 50% of people struggle to take them. Consequently, demand for easy-to-swallow oral dosage forms, such as orally disintegrating granules (ODGs), chewable tablets, lozenges, instant drinks, and effervescents, is soaring, with healthcare companies seeking to add them to their portfolios.<\/p>\n<\/div><\/section>
\n
\n